Volume 22, Issue 1 pp. 152-157
APLAR Grand Round Case

Reduced efficacy of transcatheter and surgical revascularization in Takayasu arteritis

Anthony M. Sammel

Corresponding Author

Anthony M. Sammel

Department of Rheumatology, Prince of Wales Hospital, Sydney, NSW, Australia

Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia

Correspondence: Anthony M. Sammel, MBBS, Department of Rheumatology, Prince of Wales Hospital, Barker St., Randwick, NSW 2031, Australia.

Email: [email protected]

Search for more papers by this author
Hugh D. Wolfenden

Hugh D. Wolfenden

Department of Cardiothoracic Surgery, Prince of Wales Hospital, Sydney, NSW, Australia

Search for more papers by this author
Fredrick Joshua

Fredrick Joshua

Department of Rheumatology, Prince of Wales Hospital, Sydney, NSW, Australia

Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for more papers by this author
Nigel Jepson

Nigel Jepson

Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia

Department of Cardiology, Prince of Wales Hospital, Sydney, NSW, Australia

Search for more papers by this author
First published: 26 December 2014
Citations: 4

Abstract

A 55-year-old woman with newly diagnosed Takayasu arteritis was followed for 7 years, during which time she underwent bare metal stenting, drug eluting stenting and coronary bypass grafting for critical coronary and renal artery stenoses. Interventions were initially successful but restenosis occurred within 24 months for all modalities. In contrast, native vessel disease was largely stable after the introduction of immunosuppressive therapy. We advocate a conservative revascularization approach in Takayasu arteritis in the absence of critical end organ ischemia and early optimization of medical therapy.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.